The Woods Institute is now part of the Stanford Doerr School of Sustainability
Seth Ari Sim-Son Hoffman
Seth Ari Sim-Son Hoffman
Postdoctoral Scholar
Postdoctoral Medical Fellow, Infectious Diseases
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2021
Fellow in Medicine
Medicine
Infectious Diseases Fellow in the Division of Infectious Diseases & Geographic Medicine. Research to benefit underserved populations.
Dr. Seth Ari Sim-Son Hoffman is a clinical postdoctoral fellow in the Stephen P. Luby Lab within the Division of Infectious Diseases & Geographic Medicine, Stanford School of Medicine, Stanford University. His research interests include global health equity and clinical, translational, and implementation research to benefit underserved populations. He is also a current Masters in Epidemiology and Clinical Research candidate in the Department of Epidemiology & Population Health, Stanford School of Medicine, Stanford University.
Dr. Hoffman is involved in a broad portfolio of impact-driven research to benefit underserved populations including: the PI of typhoid urban water supply surveillance in Liberia; SARS-CoV-2 seroepidemiologic analysis of Gates Foundation-sponsored NORM Trial of a mask promotion/distribution intervention and large-scale study on asymptomatic transmission in Bangladesh; data analysis and publication of a typhoid conjugate vaccine (Typbar-TCV®, Bharat Biotech) rollout in Navi Mumbai, India targeting 9-month to 16-year-old children; a co-investigator on a project attempting to characterize, using shotgun metagenomic sequencing of placentae and environmental heavy metal sampling, why women in Bangladesh suffer from a disproportionately high rate of stillbirth; studying the willingness to receive a Phase II Nipah virus (NiV) vaccine and the appropriate language for communication about a NiV vaccine in Bangladesh.
Dr. Seth Ari Sim-Son Hoffman is a clinical postdoctoral fellow in the Stephen P. Luby Lab within the Division of Infectious Diseases & Geographic Medicine, Stanford School of Medicine, Stanford University. His research interests include global health equity and clinical, translational, and implementation research to benefit underserved populations. He is also a current Masters in Epidemiology and Clinical Research candidate in the Department of Epidemiology & Population Health, Stanford School of Medicine, Stanford University.
Dr. Hoffman is involved in a broad portfolio of impact-driven research to benefit underserved populations including: the PI of typhoid urban water supply surveillance in Liberia; SARS-CoV-2 seroepidemiologic analysis of Gates Foundation-sponsored NORM Trial of a mask promotion/distribution intervention and large-scale study on asymptomatic transmission in Bangladesh; data analysis and publication of a typhoid conjugate vaccine (Typbar-TCV®, Bharat Biotech) rollout in Navi Mumbai, India targeting 9-month to 16-year-old children; a co-investigator on a project attempting to characterize, using shotgun metagenomic sequencing of placentae and environmental heavy metal sampling, why women in Bangladesh suffer from a disproportionately high rate of stillbirth; studying the willingness to receive a Phase II Nipah virus (NiV) vaccine and the appropriate language for communication about a NiV vaccine in Bangladesh.
